Cardiovascular
Can RNA Therapy Redefine Hypertension Treatment?
Why long-acting angiotensinogen silencing could shift competition from daily-pill choice to durable blood-pressure control.
Whitepapers from the Nextyn desk
Long-form research on the decisions our clients are actually making. Free to read, every source linked, no form in the way.
5 whitepapers · updated 2 September 2026
Latest
What we published most recently
Cardiovascular
Respiratory
Beyond Inhalers: Where Pharma Bets Next
How biologics, specialist therapies and next-generation platforms are reshaping the respiratory growth agenda.
Metabolic
From Clinical Demand to Funded Persistence
Why obesity's next winners may be decided by access, not efficacy alone.
The library
Every whitepaper, most recent first
Cardiovascular
Can RNA Therapy Redefine Hypertension Treatment?
Why long-acting angiotensinogen silencing could shift competition from daily-pill choice to durable blood-pressure control.
Respiratory
Beyond Inhalers: Where Pharma Bets Next
How biologics, specialist therapies and next-generation platforms are reshaping the respiratory growth agenda.
Metabolic
From Clinical Demand to Funded Persistence
Why obesity's next winners may be decided by access, not efficacy alone.
Neurology
Beyond Efficacy: The Battle for MS Preference
Why route, treatment burden and care-model fit may become the next differentiators in multiple sclerosis.
Oncology
The Breast Cancer ADC Sequencing Race
The next competition is not about adding another option. It is about defining the treatment pathway: which ADC comes first, in which patient, and what it preserves or displaces after progression.
More is coming soon
The desk is writing for this practice now.
See the practice →
The index
The practices we write from
Every whitepaper comes out of one of our four practices. Pharma and biotech is where the desk has published so far; the rest are being written.
5 whitepapers
Pharma & biotech
Launch, access, medical and portfolio decisions.
Coming soonPayments & fintech
Market entry, adoption, pricing and regulation.
Coming soonRetail & CPG
Shopper, category, channel and competitive forces.
Coming soonIndustrials
Installed base, parts, service and the channel beneath.
Start here
Have a research problem of your own?
These papers came out of questions clients brought to the desk. If you have a research problem or a project you are scoping, a research lead will talk it through with you.
- 01Tell us what you are working on
A line is enough to start. No brief required.
- 02A research lead comes back
Someone from the desk, not a queue or a form response.
- 03We scope it together
Only if the work is a fit. Nothing is booked until you say so.